Literature DB >> 28364293

Parkinsonism in a patient with valosin-containing protein gene mutation showing: a case report.

Motoki Fujimaki1, Kazuaki Kanai2, Sayaka Funabe3, Masashi Takanashi1, Kazumasa Yokoyama1, Yuanzhe Li1, Nobutaka Hattori1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28364293     DOI： 10.1007/s00415-017-8467-2

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

1.  Valosin-containing protein mutation and Parkinson's disease.

Authors:  Nora Chan; Cindy Le; Perry Shieh; Tahseen Mozaffar; Manaswitha Khare; Jeff Bronstein; Virginia Kimonis
Journal:  Parkinsonism Relat Disord       Date:  2011-08-03       Impact factor: 4.891

2.  Mutant valosin-containing protein causes a novel type of frontotemporal dementia.

Authors:  Rolf Schröder; Giles D J Watts; Sarju G Mehta; Bernd O Evert; Petra Broich; Klaus Fliessbach; Katharina Pauls; Volkmar H Hans; Virginia Kimonis; Dietmar R Thal
Journal:  Ann Neurol       Date:  2005-03       Impact factor: 10.422

3.  Characterization of the Asian myopathy patients with VCP mutations.

Authors:  Z Shi; Y K Hayashi; S Mitsuhashi; K Goto; D Kaneda; Y-C Choi; C Toyoda; S Hieda; T Kamiyama; H Sato; M Wada; S Noguchi; I Nonaka; I Nishino
Journal:  Eur J Neurol       Date:  2011-10-31       Impact factor: 6.089

4.  Exome sequencing reveals VCP mutations as a cause of familial ALS.

Authors:  Janel O Johnson; Jessica Mandrioli; Michael Benatar; Yevgeniya Abramzon; Vivianna M Van Deerlin; John Q Trojanowski; J Raphael Gibbs; Maura Brunetti; Susan Gronka; Joanne Wuu; Jinhui Ding; Leo McCluskey; Maria Martinez-Lage; Dana Falcone; Dena G Hernandez; Sampath Arepalli; Sean Chong; Jennifer C Schymick; Jeffrey Rothstein; Francesco Landi; Yong-Dong Wang; Andrea Calvo; Gabriele Mora; Mario Sabatelli; Maria Rosaria Monsurrò; Stefania Battistini; Fabrizio Salvi; Rossella Spataro; Patrizia Sola; Giuseppe Borghero; Giuliana Galassi; Sonja W Scholz; J Paul Taylor; Gabriella Restagno; Adriano Chiò; Bryan J Traynor
Journal:  Neuron       Date:  2010-12-09       Impact factor: 17.173

5.  New and reliable MRI diagnosis for progressive supranuclear palsy.

Authors:  H Oba; A Yagishita; H Terada; A J Barkovich; K Kutomi; T Yamauchi; S Furui; T Shimizu; M Uchigata; K Matsumura; M Sonoo; M Sakai; K Takada; A Harasawa; K Takeshita; H Kohtake; H Tanaka; S Suzuki
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

6.  MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

Authors:  Aldo Quattrone; Giuseppe Nicoletti; Demetrio Messina; Francesco Fera; Francesca Condino; Pierfrancesco Pugliese; Pierluigi Lanza; Paolo Barone; Letterio Morgante; Mario Zappia; Umberto Aguglia; Olivier Gallo
Journal:  Radiology       Date:  2007-11-08       Impact factor: 11.105

7.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

Review 8.  Parkinsonian syndrome in familial frontotemporal dementia.

Authors:  Joanna Siuda; Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2014-06-13       Impact factor: 4.891

9.  Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis.

Authors:  Paloma González-Pérez; Elizabeth T Cirulli; Vivian E Drory; Ron Dabby; Puiu Nisipeanu; Ralph L Carasso; Menachem Sadeh; Andrew Fox; Barry W Festoff; Peter C Sapp; Diane McKenna-Yasek; David B Goldstein; Robert H Brown; Sergiu C Blumen
Journal:  Neurology       Date:  2012-11-14       Impact factor: 9.910

10.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.

Authors:  Giles D J Watts; Jill Wymer; Margaret J Kovach; Sarju G Mehta; Steven Mumm; Daniel Darvish; Alan Pestronk; Michael P Whyte; Virginia E Kimonis
Journal:  Nat Genet       Date:  2004-03-21       Impact factor: 38.330
  10 in total
  1 in total

1.  VCP expression decrease as a biomarker of preclinical and early clinical stages of Parkinson's disease.

Authors:  Anelya Alieva; Margarita Rudenok; Elena Filatova; Alexey Karabanov; Olga Doronina; Kseniya Doronina; Anna Kolacheva; Mikhail Ugrumov; Sergey Illarioshkin; Petr Slominsky; Maria Shadrina
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.